Emergency pharmacy migalastat 123 MG capsule NDC 71904-0100-01
Ended Awarded
- Contract number
- 36C26126N0331
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $22,840
Award facts
- Contract value 100% obligated
- $22,839.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order to Amicus Therapeutics US, LLC on February 10, 2026, for emergency pharmacy supply of Migalastat 123 mg capsules (Galafold), an FDA-approved enzyme replacement therapy for treating Fabry disease in veterans. This firm fixed-price delivery order, valued at $22,839.61 with a completion date of April 11, 2026, carries no set-aside designation and will be performed at a VA facility in Philadelphia, Pennsylvania. The award represents a task order under Amicus Therapeutics' multiple-award Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), valued at $13.0 million and effective through August 31, 2029.
Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., serves as the sole prime contractor with no subcontractor involvement, maintaining complete control over the specialized supply chain for this critical rare disease medication. The company has consistently supplied Galafold to the VA through over 150 delivery orders since March 2021 across multiple Veterans Integrated Service Networks nationwide, demonstrating established capability in fulfilling both routine pharmaceutical requirements and emergency pharmacy purchases essential to veteran healthcare. This delivery order reflects the VA's ongoing procurement of specialized treatments for rare genetic diseases through established federal supply schedule mechanisms.
Quick answers
Who was awarded contract 36C26126N0331?
36C26126N0331 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on February 10, 2026.
How much is contract 36C26126N0331 worth?
The government has obligated $22,840 on 36C26126N0331.
Is contract 36C26126N0331 an order under another contract?
Yes. 36C26126N0331 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26126N0331 competed?
The extent of competition for 36C26126N0331 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award